Trials in New York, New York
Here are the top 10 medical studies for lung cancer in New York, New York
Popular Filters
Phase 3 Trials
Anti-metabolites
Pembrolizumab + Chemotherapy for Lung Cancer
Recruiting2 awardsPhase 3
Jonesboro, Arkansas
This trial is studying whether giving first-line pembrolizumab followed by pemetrexed and carboplatin with or without pembrolizumab works better in treating patients with advanced non-squamous non-small cell lung cancer.
Immunotherapy for Small Cell Lung Cancer
Recruiting1 awardPhase 3
Hamilton, Ontario
This trial is testing whether Durvalumab alone or with Tremelimumab can help patients with a specific type of lung cancer who have already had initial treatment. The drugs aim to boost the immune system to fight off any remaining cancer cells. Durvalumab and Tremelimumab are being studied together for their potential to improve cancer treatment outcomes.
Monoclonal Antibodies
Pembrolizumab + Chemotherapy ± Canakinumab for Non-Small Cell Lung Cancer
Recruiting1 awardPhase 3
Toronto, Ontario
This trial is testing a new cancer treatment that combines two drugs, one that helps the chemotherapy work better and one that fights the cancer cells directly. The goal is to see if this new treatment is more effective and has fewer side effects than current treatments.
Tyrosine Kinase Inhibitor
Sitravatinib + Nivolumab for Advanced Non-Small Cell Lung Cancer
Recruiting2 awardsPhase 3
Johnson City, New York
This trial will compare the effectiveness of sitravatinib when given with nivolumab versus docetaxel in patients with advanced non-squamous NSCLC who have previously experienced disease progression after platinum-based chemotherapy and checkpoint inhibitor therapy.
Trials With No Placebo
Anti-metabolites
Pembrolizumab + Chemotherapy for Lung Cancer
Recruiting2 awardsPhase 3
Jonesboro, Arkansas
This trial is studying whether giving first-line pembrolizumab followed by pemetrexed and carboplatin with or without pembrolizumab works better in treating patients with advanced non-squamous non-small cell lung cancer.
Monoclonal Antibodies
Lorigerlimab for Advanced Solid Tumors
Recruiting1 awardPhase 1
Erie, Pennsylvania
This trial is testing a new drug, lorigerlimab, to see if it is safe and effective in treating patients with advanced solid tumors. The trial will first determine the maximum tolerated dose of the drug, and then expand to test its efficacy in specific tumor types.
Photosensitizer
Photodynamic Therapy for Lung Cancer
Recruiting1 awardPhase 1 & 2
Buffalo, New York
This trial studies a treatment where a special drug is injected and then activated by a laser to shrink tumors in lung cancer patients whose cancer has spread. The goal is to see if this method can safely reduce tumor size.
View More Related Trials
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.